skip to main content

Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases.(Report)

Gillams, Alice ; Khan, Zahid ; Osborn, Peter ; Lees, William

CardioVascular and Interventional Radiology, June, 2013, Vol.36(3), p.724(7) [Peer Reviewed Journal]

Full text available

Citations Cited by
  • Title:
    Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases.(Report)
  • Author: Gillams, Alice ; Khan, Zahid ; Osborn, Peter ; Lees, William
  • Subjects: Lung Cancer -- Patient Outcomes ; Lung Cancer -- Analysis ; Ablation (Surgery) -- Analysis ; Cancer Metastasis -- Patient Outcomes ; Cancer Metastasis -- Analysis ; Chemotherapy -- Analysis
  • Is Part Of: CardioVascular and Interventional Radiology, June, 2013, Vol.36(3), p.724(7)
  • Description: Byline: Alice Gillams (1), Zahid Khan (2), Peter Osborn (3), William Lees (4) Keywords: Colorectal lung metastases; Lung tumor ablation; Pulmonary ablation; Radiofrequency ablation; Thermal ablation Abstract: Purpose To analyze the factors associated with favorable survival in patients with inoperable colorectal lung metastases treated with percutaneous image-guided radiofrequency ablation. Methods Between 2002 and 2011, a total of 398 metastases were ablated in 122 patients (87 male, median age 68 years, range 29--90 years) at 256 procedures. Percutaneous CT-guided cool-tip radiofrequency ablation was performed under sedation/general anesthesia. Maximum tumor size, number of tumors ablated, number of procedures, concurrent/prior liver ablation, previous liver or lung resection, systemic chemotherapy, disease-free interval from primary resection to lung metastasis, and survival from first ablation were recorded prospectively. Kaplan--Meier analysis was performed, and factors were compared by log rank test. Results The initial number of metastases ablated was 2.3 (range 1--8) the total number was 3.3 (range 1--15). The maximum tumor diameter was 1.7 (range 0.5--4) cm, and the number of procedures was 2 (range 1--10). The major complication rate was 3.9 %. Overall median and 3-year survival rate were 41 months and 57 %. Survival was better in patients with smaller tumors--a median of 51 months, with 3-year survival of 64 % for tumors 2 cm or smaller versus 31 months and 44 % for tumors 2.1--4 cm (p = 0.08). The number of metastases ablated and whether the tumors were unilateral or bilateral did not affect survival. The presence of treated liver metastases, systemic chemotherapy, or prior lung resection did not affect survival. Conclusion Three-year survival of 57 % in patients with inoperable colorectal lung metastases is better than would be expected with chemotherapy alone. Patients with inoperable but small-volume colorectal lung metastases should be referred for ablation. Author Affiliation: (1) Radiology Department, The London Clinic, 20 Devonshire Place, London, W1G 6BW, UK (2) Countess of Chester Hospital, Liverpool Road, Chester, CH2 1UL, UK (3) Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY, UK (4) University College London Medical School, 235 Euston Road, London, Greater London, NW1 2BU, UK Article History: Registration Date: 28/09/2012 Received Date: 26/06/2012 Accepted Date: 14/09/2012 Online Date: 17/10/2012
  • Language: English
  • Identifier: ISSN: 0174-1551
  • Source: Cengage Learning, Inc.

Searching Remote Databases, Please Wait